PYC 8.33% 11.0¢ pyc therapeutics limited

Ann: Half Yearly Report and Accounts, page-5

  1. 211 Posts.
    lightbulb Created with Sketch. 32
    How much further down the track does 26m get us ?
    yes its all very frustrating and i doubt the safety results will have any SP affect IMO, its the first signs of efficacy we need maybe after mid year IMO.
    I think we get more frustrated now with the SP here & possibilities of a CR for how close we may be to a rerate by year end....or before on efficacy.
    The thing I hang onto is that management don't seem too concerned about less than attractive deals, indicating they are ok to go it on their own........reeks confidence IMO, & maybe we do need to tuff it out until a + efficacy result to attract better partnership deals.
    I think if there is a CR, I'd rather it be institutional for confidence sake. How much more can Tribe own at 46 % !!!!
    We can always load up on the market for similar generally after the fact if we like. Who knows, diluted yes but cashed up awaiting imminent results may pump the SP.........GLTAH.
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
11.0¢
Change
-0.010(8.33%)
Mkt cap ! $513.2M
Open High Low Value Volume
12.0¢ 12.5¢ 11.0¢ $383.6K 3.159M

Buyers (Bids)

No. Vol. Price($)
5 169997 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 1549 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.